FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000524003: MOVED TO association reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001152012 MOVED TO association reference set en Synonym Active Case sensitive SNOMED CT model component
900000000001153019 MOVED TO association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component

22626 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
MOVED TO association reference set Is a Historical association true Inferred relationship Some
Members associationTargetComponent
[X]Acute poliomyelitis, unspecified HSCIC (UK) Namespace 1000000
[X]Acute polymorphic psychotic disorder with symptoms of schizophrenia HSCIC (UK) Namespace 1000000
[X]Acute polymorphic psychotic disorder without symptoms of schizophrenia HSCIC (UK) Namespace 1000000
[X]Acute skin change due to ultraviolet radiation, unspecified HSCIC (UK) Namespace 1000000
[X]Acute skin change due to ultraviolet radiation, unspecified HSCIC (UK) Namespace 1000000
[X]Acute tonsillitis due to other specified organisms HSCIC (UK) Namespace 1000000
[X]Acute transmural myocardial infarction of unspecified site HSCIC (UK) Namespace 1000000
[X]Acute transmural myocardial infarction of unspecified site HSCIC (UK) Namespace 1000000
[X]Addictive personality HSCIC (UK) Namespace 1000000
[X]Additional blood and blood-forming organ disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional circulatory system disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional congenital disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional digestive system disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional endocrine, nutritional, metabolic and immunity disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional genitourinary disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional health status and health service contact classification terms HSCIC (UK) Namespace 1000000
[X]Additional infectious disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional injury and poisoning disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional musculoskeletal and connective tissue disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional neoplasm classification terms HSCIC (UK) Namespace 1000000
[X]Additional nervous system and sense organ disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional perinatal disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional pregnancy, childbirth and puerperium disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional respiratory disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional skin and subcutaneous tissue disease classification terms HSCIC (UK) Namespace 1000000
[X]Additional symptom, signs and abnormal clinical and laboratory findings classification terms HSCIC (UK) Namespace 1000000
[X]Adenovirus as the cause of diseases classified to other chapters HSCIC (UK) Namespace 1000000
[X]Adenovirus as the cause of diseases classified to other chapters HSCIC (UK) Namespace 1000000
[X]Adenovirus infection, unspecified HSCIC (UK) Namespace 1000000
[X]Adjustment and management of other implanted devices HSCIC (UK) Namespace 1000000
[X]Adjustment and management of unspecified implanted device HSCIC (UK) Namespace 1000000
[X]Adult osteomalacia, unspecified HSCIC (UK) Namespace 1000000
[X]Adverse drug reaction: [ENT] or [dental] or [NOS] or [unspecified topical agents] HSCIC (UK) Namespace 1000000
[X]Adverse reaction drug primarily affecting nervous system: [autonomic] or [CNS] HSCIC (UK) Namespace 1000000
[X]Adverse reaction to alkalising &/or acidifying agents HSCIC (UK) Namespace 1000000
[X]Adverse reaction to anti-infective: [unspecified systemic &/or antiparasitics - therapeutic] or [NOS] HSCIC (UK) Namespace 1000000
[X]Adverse reaction to blood substitutes: [macromolecular] or [plasma] HSCIC (UK) Namespace 1000000
[X]Adverse reaction to caffeine HSCIC (UK) Namespace 1000000
[X]Adverse reaction to enzymes: [NOS] or [NEC] HSCIC (UK) Namespace 1000000
[X]Adverse reaction to oral contraceptive: [therapeutic] or [unspecified] HSCIC (UK) Namespace 1000000
[X]Adverse reaction to other drug: [ENT] or [dental] or [NOS] or [unspecified topical agents] HSCIC (UK) Namespace 1000000
[X]African trypanosomiasis, unspecified HSCIC (UK) Namespace 1000000
[X]Agents affecting calcification causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Agents affecting uric acid metabolism causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Agents primarily acting on smooth and skeletal muscles and the respiratory system causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Agents primarily affecting bone metabolism causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Agents primarily affecting nutrition causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Agents primarily affecting water-balance and mineral and uric acid metabolism causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Air and space transport accidents HSCIC (UK) Namespace 1000000
[X]Airway disease due to other specific organic dusts HSCIC (UK) Namespace 1000000
[X]Alcohol deterrents causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Allergic contact dermatitis due to other agents HSCIC (UK) Namespace 1000000
[X]Allergic contact dermatitis due to other chemical products HSCIC (UK) Namespace 1000000
[X]Alpha-adrenoreceptor antagonists causing adverse effects in therapeutic use, not elsewhere classified HSCIC (UK) Namespace 1000000
[X]Amoebiasis, unspecified HSCIC (UK) Namespace 1000000
[X]Amoebic infection of other sites HSCIC (UK) Namespace 1000000
[X]Aminoglycosides causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Amputation of limb(s) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure HSCIC (UK) Namespace 1000000
[X]Analeptics causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Androgens and anabolic congeners causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Anaemia (nonmegaloblastic) associated with other specified nutritional deficiencies HSCIC (UK) Namespace 1000000
[X]Anemia in other chronic diseases classified elsewhere HSCIC (UK) Namespace 1000000
[X]Anaesthesiology devices associated with adverse incidents HSCIC (UK) Namespace 1000000
[X]Anaesthesiology devices associated with adverse incidents, diagnostic and monitoring devices HSCIC (UK) Namespace 1000000
[X]Anaesthesiology devices associated with adverse incidents, miscellaneous devices, not elsewhere classified HSCIC (UK) Namespace 1000000
[X]Anaesthesiology devices associated with adverse incidents, prosthetic and other implants, materials and accessory devices HSCIC (UK) Namespace 1000000
[X]Anaesthesiology devices associated with adverse incidents, surgical instruments, materials and devices (including sutures) HSCIC (UK) Namespace 1000000
[X]Anaesthesiology devices associated with adverse incidents, therapeutic (nonsurgical) and rehabilitative devices HSCIC (UK) Namespace 1000000
[X]Anaesthetics and therapeutic gases causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Aneurysm of aorta in diseases classified elsewhere HSCIC (UK) Namespace 1000000
[X]Aneurysm of other specified arteries HSCIC (UK) Namespace 1000000
[X]Angiotensin II receptor antagonists causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Angiotensin-converting-enzyme inhibitors causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Animal-rider or occupant of animal-drawn vehicle injured in transport accident HSCIC (UK) Namespace 1000000
[X]Anogenital herpes viral infection, unspecified HSCIC (UK) Namespace 1000000
[X]Anomalies of pupillary function in diseases classified elsewhere HSCIC (UK) Namespace 1000000
[X]Antenatal screening for fetal growth retardation using ultrasonics and other physical methods HSCIC (UK) Namespace 1000000
[X]Antenatal screening for malformations using ultrasonics and other physical methods HSCIC (UK) Namespace 1000000
[X]Anthrax, unspecified HSCIC (UK) Namespace 1000000
[X]Anti-common-cold drugs causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antiallergic and antiemetic drugs causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antiasthmatics causing adverse effects in therapeutic use, not elsewhere classified HSCIC (UK) Namespace 1000000
[X]Anticholinesterase agents causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Anticoagulant antagonists, vitamin K and other coagulants causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Anticoagulants causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antidiarrhoeal drugs causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antidotes and chelating agents causing adverse effects in therapeutic use, not elsewhere classified HSCIC (UK) Namespace 1000000
[X]Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antigonadotrophins, antioestrogens, antiandrogens causing adverse effects in therapeutic use, not elsewhere classified HSCIC (UK) Namespace 1000000
[X]Antihelminthics causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antihyperlipidaemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antimalarials and drugs acting on other blood protozoa causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antimycobacterial drugs causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antineoplastic antimetabolites causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antineoplastic natural products causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antiparkinsonism drugs causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000
[X]Antipruritics causing adverse effects in therapeutic use HSCIC (UK) Namespace 1000000

Start Previous Page 160 of 227 Next End

Reference Sets

Reference set descriptor

Back to Start